Cartalax

Description

Cartalax is a short synthetic peptide supplied as a research reagent for in-vitro laboratory use. It sits in the peptide bioregulator group that researchers working in connective tissue, cartilage and cellular aging models tend to source alongside other short-chain sequences. If you are sourcing research peptides in Canada and need material you can document, this one ships as a lyophilized vial with a certificate of analysis tied to the batch you actually receive.

Overview

Each unit is a single 20mg vial of lyophilized Cartalax, sealed and stored cold until dispatch. A box of ten vials is available for labs running longer protocols or multiple arms of an experiment without wanting to re-qualify a new lot mid-study. The powder is intended for reconstitution in a suitable research solvent chosen by the end user according to their protocol; no diluent is included, since solvent selection depends entirely on the assay. Orders leave our facility in Canada in discreet packaging with nationwide tracking. This is a laboratory reagent — not a drug, supplement, food or cosmetic — and it is not for human or veterinary use.

What it is known for

Buyers choose this listing for the paperwork as much as the peptide. Every lot goes to Janoshik, an independent analytical laboratory, for purity by HPLC and identity confirmation by mass spectrometry, and the resulting certificate of analysis is matched to the batch in the vial rather than to a representative sample from some earlier production run. For a short peptide like Cartalax, where visual inspection tells you nothing, that independent identity confirmation is the only practical assurance that what is in the vial is what the label says. Sourcing domestically also removes the customs delays and temperature exposure that make imported reagents unpredictable.

Key features

• Lyophilized powder format — Freeze-dried peptide is far more stable in storage than material in solution, so the vial holds its integrity until you are ready to reconstitute and you control the solvent and concentration your protocol calls for.
• Independent HPLC purity testing — Purity is quantified by a lab with no commercial stake in the result, so you know how much of the mass in the vial is target peptide rather than process residue — which matters the moment you calculate a working concentration.
• Mass spectrometry identity confirmation — Confirms the molecular identity of the material, ruling out a mislabeled or substituted sequence before it enters your experiment.
• Batch-matched certificate of analysis — The COA corresponds to your specific lot, so it can be cited in a methods section, filed for lab records, or used to satisfy internal QA without caveats.
• 20mg fill per vial — A working quantity for in-vitro use that reduces how often you open and re-handle stock, limiting moisture exposure and cross-contamination risk.
• Box of ten option — Lets a lab run an extended or multi-arm study on consistent material, so results are not confounded by a lot change partway through.
• Cold storage before dispatch — The vial is held under refrigeration rather than sitting on an ambient shelf, so the condition you receive reflects the condition it was tested in.
• Domestic Canadian shipping with tracking — No border clearance, shorter transit and a trackable parcel — less time in transit is less opportunity for temperature abuse, and you can plan lab work around a known arrival.

Benefits

• You can document exactly what went into an experiment, with third-party analytical data attached to your specific lot.
• Reconstitution is on your terms — solvent, concentration and aliquoting all stay under your control.
• Consistent material across a multi-vial order supports reproducibility from run to run.
• Domestic dispatch shortens the gap between ordering and starting work, and keeps the parcel out of customs.
• Discreet, tracked packaging suits both institutional receiving departments and smaller private labs.

Specifications

Typical applications

• In-vitro research within connective tissue and cellular aging models
• Comparative work alongside other short-chain peptide bioregulators
• Method development and analytical reference work where a documented lot is required
• Academic, biotech and independent laboratory studies needing traceable reagent sourcing

Important information

• Store the sealed lyophilized vial cold and protected from light and moisture; return it to cold storage promptly after handling.
• Choose and prepare a reconstitution solvent appropriate to your protocol — none is supplied, and solvent choice affects solubility and stability.
• Once reconstituted, handle as you would any peptide solution: aliquot to avoid repeated freeze-thaw cycles and keep refrigerated or frozen per your lab’s practice.
• Request the certificate of analysis for your batch and file it with your experimental records.
• Not for human or veterinary use, ingestion or administration. Not a drug, supplement, food or cosmetic, and not intended to diagnose, treat, cure or prevent any disease.

Common questions

What is included in the vial?

20mg of lyophilized Cartalax powder, sealed. No solvent, syringe or diluent is included, since reconstitution parameters are determined by your protocol.

Who performs the testing?

Janoshik, an independent third-party analytical laboratory, tests each batch for purity by HPLC and identity by mass spectrometry.

Can I see the certificate of analysis for my batch?

Yes. A batch-matched COA is available, so the data you receive corresponds to the lot in your vial rather than to an earlier production run.

How should I store it before use?

Keep the sealed vial cold, dry and away from light. Lyophilized peptide is considerably more stable than reconstituted solution, so leave it in powder form until you need it.

Why buy the box of ten?

Ten vials of the same lot means one set of analytical data covers an entire study, which removes lot-to-lot variation as a variable in longer or multi-arm experiments.

Is this suitable for human use?

No. Cartalax is supplied strictly as a laboratory research reagent for in-vitro use. It is not a drug, supplement, food or cosmetic and is not intended for human or veterinary administration.

In summary

A 20mg lyophilized vial of Cartalax with independent HPLC purity and MS identity data behind it, a certificate of analysis tied to your batch, and cold-stored dispatch from within Canada. Single vials for exploratory work, boxes of ten for studies that need one consistent lot from start to finish.